Cargando…

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells

Missense p53 mutations (mutp53) occur in approx. 70% of pancreatic ductal adenocarcinomas (PDAC). Typically, mutp53 proteins are aberrantly stabilized by Hsp90/Hsp70/Hsp40 chaperone complexes. Notably, stabilization is a precondition for specific mutp53 alleles to acquire powerful neomorphic oncogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klemke, Luisa, Fehlau, Clara F., Winkler, Nadine, Toboll, Felicia, Singh, Shiv K., Moll, Ute M., Schulz-Heddergott, Ramona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226097/ https://www.ncbi.nlm.nih.gov/pubmed/34178628 http://dx.doi.org/10.3389/fonc.2021.642603

Ejemplares similares

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
por: Isermann, Tamara, et al.
Publicado: (2021)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer
por: Klemke, Luisa, et al.
Publicado: (2021)

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
por: Brown, Kate, et al.
Publicado: (2023)

Differential Regulation of Cutaneous Oncoprotein HPVE6 by wtp53, Mutant p53R248W and ΔNp63α is HPV Type Dependent
por: Fei, Jian-Wei, et al.
Publicado: (2012)

Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing
por: Xu, An, et al.
Publicado: (2018)

Gain of function of mutant p53: R282W on the peak?
por: Zhang, Y, et al.
Publicado: (2016)

Diverse and cancer type-specific roles of the p53 R248Q gain-of-function mutation in cancer migration and invasiveness
por: Olszewski, Maciej Boleslaw, et al.
Publicado: (2019)

Gain-of-function hot spot mutant p53(R248Q) regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma
por: Yu, Valen Zhuoyou, et al.
Publicado: (2020)

P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
por: Hsieh, Yao-Yuan, et al.
Publicado: (2006)

Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteins
por: Tutuska, Karis, et al.
Publicado: (2020)

The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53
por: Piqué-Borràs, Maria-Riera, et al.
Publicado: (2023)

The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression
por: De Souza, Cristabelle, et al.
Publicado: (2020)

Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
por: Allende-Vega, Nerea, et al.
Publicado: (2019)

Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor
por: Lai, Zih-Yin, et al.
Publicado: (2021)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Effects of Temperature on the p53-DNA Binding Interactions and Their Dynamical Behavior: Comparing the Wild Type to the R248Q Mutant
por: Barakat, Khaled, et al.
Publicado: (2011)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient
por: Shtraizent, Nataly, et al.
Publicado: (2015)

Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression
por: Yang, Yue, et al.
Publicado: (2019)

Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53
por: Datta, Arindam, et al.
Publicado: (2019)

Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
por: Jovanović, Katarina K., et al.
Publicado: (2019)

Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC
por: Zhou, Yaodong, et al.
Publicado: (2020)

P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022)

Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach
por: Balasundaram, Ambritha, et al.
Publicado: (2022)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
por: Fang, Y., et al.
Publicado: (2022)

HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates
por: Schulz, Ramona, et al.
Publicado: (2012)

Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU via TCF21/CD44 Axis-Mediated Enhanced Stemness in Colorectal Carcinoma
por: Gao, Xiaolei, et al.
Publicado: (2022)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

p53 further extends its reach
por: Zirngibl, Katharina, et al.
Publicado: (2013)

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
por: Michalides, R., et al.
Publicado: (1996)

Correction to Lancet Oncol 2016; 17: 248, 252
Publicado: (2016)

hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions
por: Silva, Tanielly Cristina Raiol, et al.
Publicado: (2012)

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
por: Herrero, Ana B., et al.
Publicado: (2016)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_619l80goano7d7ar9rjuhbfbvn